Related Experiment Video
Updated: Mar 14, 2026

06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.6K
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
Roberta Visconti1, Rosa Della Monica2,3, Domenico Grieco4,5
1IEOS, CNR, Via S. Pansini 5, 80131, Naples, Italy. r.visconti@ieos.cnr.it.
Journal of Experimental & Clinical Cancer Research : CR
|September 28, 2016
Summary
Targeting cell cycle checkpoints, the cell's safeguard mechanisms, offers new strategies to enhance cancer therapy. Manipulating these checkpoints can improve existing treatments and directly kill cancer cells.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Current anticancer therapeutics often damage DNA or disrupt cell division.
- Cell cycle checkpoints are crucial safeguard mechanisms that respond to cellular damage.
- Cancer cells may have defects in checkpoint control, presenting therapeutic vulnerabilities.
Approach:
- This review summarizes emerging concepts in targeting cell cycle checkpoints for cancer treatment.
- It explores the biochemical mechanisms underlying various checkpoints.
- The focus is on chemical manipulation of these pathways.
Key Points:
- Cell cycle checkpoints are essential for cell cycle progression, DNA repair, and apoptosis.
- Understanding checkpoint regulation provides novel therapeutic targets.
- Targeting checkpoints can sensitize cancer cells to conventional therapies or induce cell death directly.
Conclusions:
- Targeting cell cycle checkpoints represents a promising strategy to improve cancer therapy efficacy.
- New therapeutic approaches are being developed based on checkpoint manipulation.
- This strategy aims to enhance cancer cell killing and overcome treatment resistance.
Related Concept Videos
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity
5.6K
5.6K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules
136.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.9K

